title: Biosimilars G-CSF versus originator G-CSF in post allotransplant recovery. A case-control study.
authors.affiliation: Ospedale Oncologico Di Riferimento Regionale "Armando Businco", Unità Operativa Ematologia E Centro Trapianti, Cagliari, Italy.
authors.forename: Clara
authors.initials: C
authors.lastname: Targhetta
authors.affiliation: Ospedale Oncologico Di Riferimento Regionale "Armando Businco", Unità Operativa Ematologia E Centro Trapianti, Cagliari, Italy.
authors.forename: Donatella
authors.initials: D
authors.lastname: Baronciani
authors.affiliation: Dipartimento Di Medicina Molecolare E Biotecnologie Mediche, , Università Degli Studi Di Napoli "Federico II", Napoli, Italy.|CEINGE Biotecnologie Avanzate, Napoli, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Capasso
authors.affiliation: Ospedale Oncologico Di Riferimento Regionale "Armando Businco", Unità Operativa Ematologia E Centro Trapianti, Cagliari, Italy.
authors.forename: Cristina
authors.initials: C
authors.lastname: Depau
authors.affiliation: Ospedale Oncologico Di Riferimento Regionale "Armando Businco", Unità Operativa Ematologia E Centro Trapianti, Cagliari, Italy.
authors.forename: Igor
authors.initials: I
authors.lastname: Tandurella
authors.affiliation: Servizio Di Farmacia, Ospedale Oncologico Di Riferimento Regionale "Armando Businco", Cagliari, Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Giuseppina Corona
authors.affiliation: Ospedale Oncologico Di Riferimento Regionale "Armando Businco", Unità Operativa Ematologia E Centro Trapianti, Cagliari, Italy.
authors.forename: Emanuele
authors.initials: E
authors.lastname: Angelucci
mesh_terms: D064591:Allografts; D059451:Biosimilar Pharmaceuticals / Q000008:administration & dosage / Q000627:therapeutic use*; D016022:Case-Control Studies; D000069585:Filgrastim / Q000008:administration & dosage / Q000627:therapeutic use*; D006401:Hematologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D009503:Neutropenia / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D059451:Biosimilar Pharmaceuticals; D006401:Hematologic Agents; D000069585:Filgrastim